dr. davids on the combination of ibrutinib and obinutuzumab in cll
Published 6 years ago • 580 plays • Length 2:34Download video MP4
Download video MP3
Similar videos
-
1:09
dr. davids on results of obinutuzumab with ibrutinib
-
1:07
dr. davids on the potential utility of ibrutinib/umbralisib in mcl and cll
-
0:47
dr. davids on the potential utility of frontline ibrutinib/umbralisib in mcl and cll
-
2:18
the combination of ibrutinib and obinutuzumab in cll
-
7:01
novel frontline combinations with ibrutinib in cll
-
1:22
dr. davids on updated data with ibrutinib/umbralisib in r/r cll and mcl
-
1:36
dr. davids on cost effectiveness of time-limited therapy with venetoclax/obinutuzumab in cll
-
2:41
the power of seeds in nerve health | dr. chisie klinglesmith
-
1:17
dr. davids on ibrutinib plus fcr in younger patients with cll
-
1:22
dr. davids on rationale for ibrutinib/umbralisib combo in r/r cll and mcl
-
0:47
dr. davids on remaining questions with umbralisib/ibrutinib in cll and mcl
-
1:09
dr. davids discusses the results of ibrutinib plus fcr in cll
-
1:14
dr. davids on exciting data with acalabrutinib in cll
-
4:31
sequence of administration of ibrutinib with obinutuzumab in r/r cll patients
-
3:33
dr. matthew davids on advances in cll treatment | dana-farber cancer institute
-
1:25
dr. rogers discusses obinutuzumab, ibrutinib, and venetoclax combination in cll
-
0:59
dr. davids on frontline challenges in cll
-
0:53
dr. kambhampati on frontline ibrutinib plus obinutuzumab in cll
-
1:44
ibrutinib and fcr in cll irrespective of ighv mutation status